These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31300287)
1. Purification of rabies virus produced in Vero cells grown in serum free medium. Trabelsi K; Ben Zakour M; Kallel H Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287 [TBL] [Abstract][Full Text] [Related]
2. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
5. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification. Prem Kumar AA; Mani KR; Palaniappan C; Bhau LN; Swaminathan K Microbes Infect; 2005 Jul; 7(9-10):1110-6. PubMed ID: 16046167 [TBL] [Abstract][Full Text] [Related]
6. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697 [TBL] [Abstract][Full Text] [Related]
7. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask. Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056 [TBL] [Abstract][Full Text] [Related]
8. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
9. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733 [TBL] [Abstract][Full Text] [Related]
10. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. Frazzati-Gallina NM; Paoli RL; Mourão-Fuches RM; Jorge SA; Pereira CA J Biotechnol; 2001 Dec; 92(1):67-72. PubMed ID: 11604174 [TBL] [Abstract][Full Text] [Related]
11. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell]. Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837 [TBL] [Abstract][Full Text] [Related]
12. Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997 [TBL] [Abstract][Full Text] [Related]
13. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines. Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007 [TBL] [Abstract][Full Text] [Related]
14. Preparation of human rabies vaccine in VERO cell culture using a microcarrier system. Mendonça RZ; Ioshimoto LM; Mendonça RM; De-Franco M; Valentini EJ; Beçak W; Raw I; Pereira CA Braz J Med Biol Res; 1993 Dec; 26(12):1305-17. PubMed ID: 8136732 [TBL] [Abstract][Full Text] [Related]
15. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. Arifin MA; Mel M; Abdul Karim MI; Ideris A J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497 [TBL] [Abstract][Full Text] [Related]
16. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use. el-Karamany RM Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Jones RL; Froeschle JE; Atmar RL; Matthews JS; Sanders R; Pardalos J; Moeller L; Chin JE; Famula M; Briggs DJ; Lang J Vaccine; 2001 Sep; 19(32):4635-43. PubMed ID: 11535311 [TBL] [Abstract][Full Text] [Related]
18. Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease. Li SM; Bai FL; Xu WJ; Yang YB; An Y; Li TH; Yu YH; Li DS; Wang WF Biologicals; 2014 Sep; 42(5):271-6. PubMed ID: 25108516 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. Kallel H; Jouini A; Majoul S; Rourou S J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860 [TBL] [Abstract][Full Text] [Related]
20. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium. He C; Yang Z; Tong K J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]